Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$434K Buy
8,279
+2,933
+55% +$155K 0.02% 415
2026
Q1
$295K Buy
5,346
+764
+17% +$41.4K 0.01% 470
2025
Q4
$225K Buy
+4,582
New +$214K 0.01% 527
2025
Q1
Sell
-322
Closed -$10.9K 1104
2024
Q4
$10.9K Buy
322
+80
+33% +$2.88K ﹤0.01% 1412
2024
Q3
$9.89K Buy
242
+20
+9% +$818 ﹤0.01% 1198
2024
Q2
$8.55K Hold
222
﹤0.01% 1137
2024
Q1
$9.52K Hold
222
﹤0.01% 945
2023
Q4
$8.23K Hold
222
﹤0.01% 919
2023
Q3
$8.05K Buy
222
+7
+3% +$248 ﹤0.01% 850
2023
Q2
$7.66K Buy
215
+32
+17% +$1.15K ﹤0.01% 689
2023
Q1
$6.51K Buy
+183
New +$6.4K ﹤0.01% 781
2019
Q2
Sell
-4,140
Closed -$216K 248
2019
Q1
$216K Sell
4,140
-2,450
-37% -$122K 0.03% 233
2018
Q4
$312K Buy
+6,590
New +$325K 0.05% 203

Other funds holding GSK

Venturi Wealth Management's GSK Position: Q2 2026 in Review

Venturi Wealth Management increased its GSK (GSK) stake by 55% in Q2 2026, buying an estimated $155K and bringing the position to 8,279 shares worth $434K. The position accounts for 0.02% of the portfolio, ranked #415.

Venturi Wealth Management first reported a position in GSK in Q4 2018 and has held it in 13 quarters since. 241 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Venturi Wealth Management held 8,279 shares of GSK worth $434K as of Q2 2026.
  • Venturi Wealth Management bought 2,933 GSK shares in Q2 2026, an estimated $155K.
  • GSK made up 0.02% of Venturi Wealth Management's portfolio in Q2 2026, its #415 holding.
  • Venturi Wealth Management first reported a position in GSK in Q4 2018 and has held it in 13 quarters since.
  • 241 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.